Treatment of Iron Overload Requiring Chelation Therapy

Summary

The purpose of this open-label study is to assess liver iron concentration using MRI imaging in subjects with beta-thalassemia when administered with either SPD602 or deferasirox for the treatment of chronic transfusional iron overload.

Timeline

Start

2014-11-20

Primary completion

2015-10-30

Completion

2015-10-30

Outcome

Outcome not reported

Stopped: “This study was withdrawn until the evaluation of the nonclinical rat findings is complete.”

Publications

• Padhani ZA, Gangwani MK, Sadaf A, Hasan B, Colan S, Alvi N, Das JK. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia. Cochrane Database Syst Rev. 2023 Nov 17;11(11):CD011626. doi: 10.1002/14651858.CD011626.pub3.

Drugs

Indications